Pirani P - Search Results

1

Anti-insulin-like growth factor-I activity of a novel polysulphonated distamycin A derivative in human lung cancer cell lines.

de Cupis A, Ciomei M, Pirani P, Ferrera A, Ardizzoni A, Favoni RE. de Cupis A, et al. Among authors: pirani p. Br J Pharmacol. 1997 Feb;120(3):537-43. doi: 10.1038/sj.bjp.0700937. Br J Pharmacol. 1997. PMID: 9031761 Free PMC article.

2

Enhanced effectiveness of last generation antiblastic compounds vs. cisplatin on malignant pleural mesothelioma cell lines.

de Cupis A, Semino C, Pirani P, Loprevite M, Ardizzoni A, Favoni RE. de Cupis A, et al. Among authors: pirani p. Eur J Pharmacol. 2003 Jul 25;473(2-3):83-95. doi: 10.1016/s0014-2999(03)01907-1. Eur J Pharmacol. 2003. PMID: 12892825

3

Expression and function of the insulin-like growth factor I system in human non-small-cell lung cancer and normal lung cell lines.

Favoni RE, de Cupis A, Ravera F, Cantoni C, Pirani P, Ardizzoni A, Noonan D, Biassoni R. Favoni RE, et al. Among authors: pirani p. Int J Cancer. 1994 Mar 15;56(6):858-66. doi: 10.1002/ijc.2910560618. Int J Cancer. 1994. PMID: 7509779

4

Suramin interferes with auto/paracrine insulin-like growth factor I-controlled proliferative loop on human lung cancer cell lines.

Favoni RE, Ravera F, Pirani P, Ardizzoni A, Noonan D, de Cupis A. Favoni RE, et al. Among authors: pirani p. Eur J Pharmacol. 1994 Oct 24;264(2):199-206. doi: 10.1016/0014-2999(94)00467-6. Eur J Pharmacol. 1994. PMID: 7851483

5

Suramin-induced growth inhibition and insulin-like growth factor-I binding blockade in human breast carcinoma cell lines: potentially related events.

Ravera F, Miglietta L, Pirani P, Ferrini S, Favoni RE. Ravera F, et al. Among authors: pirani p. Eur J Cancer. 1993;29A(2):225-30. doi: 10.1016/0959-8049(93)90180-n. Eur J Cancer. 1993. PMID: 8422287

6

Comparison between novel steroid-like and conventional nonsteroidal antioestrogens in inhibiting oestradiol- and IGF-I-induced proliferation of human breast cancer-derived cells.

de Cupis A, Noonan D, Pirani P, Ferrera A, Clerico L, Favoni RE. de Cupis A, et al. Among authors: pirani p. Br J Pharmacol. 1995 Nov;116(5):2391-400. doi: 10.1111/j.1476-5381.1995.tb15085.x. Br J Pharmacol. 1995. PMID: 8581274 Free PMC article.

7

Modulation of the insulin-like growth factor-I system by N-(4-hydroxyphenyl)-retinamide in human breast cancer cell lines.

Favoni RE, de Cupis A, Bruno S, Yee D, Ferrera A, Pirani P, Costa A, Decensi A. Favoni RE, et al. Among authors: pirani p. Br J Cancer. 1998 Jun;77(12):2138-47. doi: 10.1038/bjc.1998.358. Br J Cancer. 1998. PMID: 9649125 Free PMC article.

8

Establishment and preliminary characterization of human malignant mesothelioma cell lines.

de Cupis A, Pirani P, Favoni RE. de Cupis A, et al. Among authors: pirani p. Monaldi Arch Chest Dis. 1998 Apr;53(2):188-92. Monaldi Arch Chest Dis. 1998. PMID: 9689807

9

Responsiveness to hormone, growth factor and drug treatment of a human breast cancer cell line: comparison between early and late cultures.

de Cupis A, Pirani P, Fazzuoli L, Favoni RE. de Cupis A, et al. Among authors: pirani p. In Vitro Cell Dev Biol Anim. 1998 Nov-Dec;34(10):836-43. doi: 10.1007/s11626-998-0039-4. In Vitro Cell Dev Biol Anim. 1998. PMID: 9870534

10

Pre-clinical evaluation of new antineoplastic agents in NSCLC cell lines: evidence of histological subtype-dependent cytotoxicity.

Loprevite M, Favoni RE, de Cupis A, Pirani P, Merlo F, Grossi F, Ardizzoni A. Loprevite M, et al. Among authors: pirani p. Int J Oncol. 1999 Oct;15(4):787-92. doi: 10.3892/ijo.15.4.787. Int J Oncol. 1999. PMID: 10493963

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters